Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol

Archives of Gynecology and Obstetrics

Volumn 261, Issue 4, 1998, Pages 201-208

  Suvanto Luukkonen, E ^a   Sundstrom H ^b   Penttinen, J ^c   Kauppila, A ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b KAINUU CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Hormone replacement therapy; Levonorgestrel; Lipids; Natural progesterone

Indexed keywords

CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVONORGESTREL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRAUTERINE DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; TRANSDERMAL DRUG ADMINISTRATION; TRIACYLGLYCEROL BLOOD LEVEL;

BIOLOGY; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; ESTRADIOL; ESTROGENS; EUROPE; FAMILY PLANNING; FINLAND; HORMONE REPLACEMENT THERAPY; HORMONES; IUD; IUD, HORMONE RELEASING; LEVONORGESTREL; LIPID METABOLIC EFFECTS; LIPIDS; NORTHERN EUROPE; PHYSIOLOGY; PROGESTATIONAL HORMONES; PROGESTERONE; RESEARCH METHODOLOGY; RESEARCH REPORT; SCANDINAVIA; TREATMENT;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; CHOLESTEROL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; LIPIDS; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TRIGLYCERIDES;

EID: 0031719825     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040050222     Document Type: Article

References (12)

1. Andersson K, Mattsson L-Å, Rybo G, Stadberg E (1992) Intrauterine release of levonorgestrel - a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 79: 963-967
2. Cheang A, Sitruk-Ware R, Samsioe G (1994) Transdermal oestradiol and cardiovascular risk factors. Br J Obstet Gynaecol 101: 571-581
3. Darj E, Crona N, Nilsson S (1992) Effects on lipids and lipoproteins in women treated with oestradiol and progesterone. Maturitas 15: 209-215
4. Harlap S (1992) The benefits and risks of hormone replacement therapy: an epidemiologic overview. Am J Obstet Gynecol 166: 1986-1992
5. Jensen J, Riis BJ, Strom V, Nilas L, Christiansen C (1987) Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol 156: 66-71
6. Moorjani S, Dupont A, Labrie F, De Lignieres B, Cusan L, Dupont P et al. (1991) Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women. J Clin Endocrinol Metab 73: 373-379
7. Mosnier-Pudar H, Faguer B, Guyenne T, Tchobroutsky G et al. (1991) [Effects of deprivation and replacement by percutaneous 17 beta estradiol and oral progesterone on blood pressure and metabolic parameters in menopause patients with non-insulin-dependent diabetes]. Arch Mal Coeur Vaiss 84: 1111-1115
8. Nabulsi A, Folsom A, White A, Patsch W, Heiss G, Wu K et al. (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 328: 1069-1075
9. Palacios S, Menendez C, Jurado AR, Vargas JC et al. (1994) Effects of oestradiol administration via different routes on the lipid profile in women with bilateral oophorectomy. Maturitas 18: 239-244
10. Raudaskoski T, Lahti E, Kauppila A, Apaja-Sarkkinen A, Laatikainen T (1995) Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Am J Obstet Gynecol 172: 114-119
11. Raudaskoski T, Tomás E, Paakkari I, Kauppila A, Laatikainen T (1995) Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device. Maturitas 22: 47-53
12. Suvanto-Luukkonen E, Sundström H, Penttinen J, Läärä E, Pramila S, Kauppila A (1997) Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy. Maturitas 26: 211-217